Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000627:therapeutic use*; D000526:Alprenolol / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D010096:Oxprenolol / Q000494:pharmacology; D010869:Pindolol / Q000494:pharmacology; D011217:Practolol / Q000009:adverse effects / Q000494:pharmacology; D011433:Propranolol / Q000009:adverse effects / Q000494:pharmacology; D011802:Quinidine / Q000627:therapeutic use; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol; D011802:Quinidine; D011217:Practolol